Endocrine Related Cancer · 2018 · 92 citations · 16 references
MedicineOncologyPharmacologyCancer PharmacologyMolecular OncologyNeoplasiaCancer Cell SignalingMalignant NeoplasmsMitotic InhibitorsOncology PharmacologyThyroid CancerTyrosine Kinase InhibitorsAnaplastic Thyroid Carcinoma PathologyAnticancer ActivityCancer Cell Proliferation InhibitionCell Viability AssaysKinase Inhibitor ProteinsKinase Signaling InhibitorsPoorly Differentiated Thyroid CarcinomaProtein Kinase Inhibitors
There is no effective treatment for patients with poorly differentiated papillary thyroid cancer or anaplastic thyroid cancer (ATC). Anlotinib, a multi-kinase inhibitor, has already shown antitumor effects in various types of carcinoma in a phase I clinical trial. In this study, we aimed to better understand the effect and efficacy of anlotinib against thyroid carcinoma cells in vitro and in vivo. We found that anlotinib inhibits the cell viability of papillary thyroid cancer and ATC cell lines, likely due to abnormal spindle assembly, G2/M arrest, and activation of TP53 upon anlotinib treatment. Moreover, anlotinib suppresses the migration of thyroid cancer cells in vitro and the growth of xenograft thyroid tumors in mice. Our data demonstrate that anlotinib has significant anticancer activity in thyroid cancer, and potentially offers an effective therapeutic strategy for patients of advanced thyroid cancer type.
16
Cancer statistics in China, 2015
Wanqing Chen, Rongshou Zheng, Peter D. Baade et al. · CA A Cancer Journal for Clinicians · 2016 · 18K citations · Full text
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
Robert C. Smallridge, Kenneth B. Ain, L. Sylvia et al. · Thyroid · 2012 · 935 citations · Full text
Medicine, Endocrinology, Oncology +13
Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
Mingzhao Xing, Ali S. Alzahrani, Kathryn A. Carson et al. · JAMA · 2013 · 926 citations
International patterns and trends in thyroid cancer incidence, 1973–2002
Briseis A. Kilfoy, Tongzhang Zheng, Theodore R. Holford et al. · Cancer Causes & Control · 2008 · 718 citations · Full text
Medicine, Endocrinology, Oncology +13